Follicular Non-Hodgking´s Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line.
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Trial of Rituximab, Bendamustine (RB) for Patients With Follicular Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line (NCT01127841) | Grupo Oncológico para el Tratamiento y el Estudio de los Linfomas | 2009-07-01 |
Track Follicular Non-Hodgking´s Lymphoma Refractory or Relapsed After Treatment With R-chemotherapy in First Line. automatically
Every clearance here is in the API, with alerts when new ones post.